CareRx Corp (CHHHF) reports steady Q2 2026 revenue of $93.6 million and a 10% dividend hike, while navigating a $2 million impact from Ontario ward bed funding changes.

Last week's profit announcement from CareRx Corporation ( TSE:CRRX ) was underwhelming for investors, despite headline...

As the Canadian market navigates a landscape filled with geopolitical tensions and policy shifts, fundamentals continue to steer the course, with low energy prices and moderating inflation anchoring stability. In this environment of broadening earnings and solid growth, identifying stocks that may be trading below their estimated value involves focusing on these enduring economic strengths rather than headline volatility.

As the Canadian market navigates through an eventful start to 2026, marked by geopolitical developments and economic data releases, investors are closely monitoring potential impacts on sectors such as energy. In this context, identifying undervalued stocks can be an effective strategy for those looking to capitalize on market inefficiencies and secure long-term value, with Ag Growth International and two other TSX-listed companies offering intriguing opportunities worth exploring.

Key Insights Given the large stake in the stock by institutions, CareRx's stock price might be vulnerable to their...

CareRx (TSX:CRRX) has crossed into profitability, averaging 41.4% earnings growth per year over the last five years. Revenue is projected to climb by 5.84% annually, outpacing the Canadian market’s 5.1% growth rate. The company’s improving net profit margin signals stronger operational momentum. However, results for the past 12 months were tempered by a one-off CA$1.1 million loss, a reminder that not all gains were smooth this period. See our full analysis for CareRx. Next, we’ll stack these...

CareRx Corp (CHHHF) reports robust financial performance with a third consecutive quarter of positive net income and plans to initiate a quarterly dividend.

The Canadian market continues to navigate its third year of a bull market, with the TSX gaining 67% since October 2022, supported by easing inflation and potential interest rate cuts from the Bank of Canada. As investors seek opportunities beyond established giants, penny stocks—often representing smaller or newer companies—remain a relevant area for exploration. Despite their vintage name, these stocks can offer surprising value when backed by strong financials and have the potential to...

These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But if you pick...

Stifel Canada is upgrading CareRx to Buy, with a $4.50 target. CareRx is a Canadian specialty pha